- Home
- PBYI vs ITRG Comparison
PBYI vs ITRG Comparison
Compare PBYI & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- ITRG
- Stock Information
- Founded
- PBYI 2010
- ITRG 1997
- Country
- PBYI United States
- ITRG Canada
- Employees
- PBYI N/A
- ITRG N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- ITRG Precious Metals
- Sector
- PBYI Health Care
- ITRG Basic Materials
- Exchange
- PBYI Nasdaq
- ITRG Nasdaq
- Market Cap
- PBYI 153.2M
- ITRG 156.9M
- IPO Year
- PBYI N/A
- ITRG N/A
- Fundamental
- Price
- PBYI $2.92
- ITRG $0.91
- Analyst Decision
- PBYI Strong Buy
- ITRG Strong Buy
- Analyst Count
- PBYI 1
- ITRG 1
- Target Price
- PBYI $7.00
- ITRG $3.75
- AVG Volume (30 Days)
- PBYI 416.5K
- ITRG 309.1K
- Earning Date
- PBYI 11-07-2024
- ITRG 11-13-2024
- Dividend Yield
- PBYI N/A
- ITRG N/A
- EPS Growth
- PBYI 492.79
- ITRG N/A
- EPS
- PBYI 0.47
- ITRG N/A
- Revenue
- PBYI $243,569,000.00
- ITRG N/A
- Revenue This Year
- PBYI N/A
- ITRG N/A
- Revenue Next Year
- PBYI N/A
- ITRG $360.52
- P/E Ratio
- PBYI $6.26
- ITRG N/A
- Revenue Growth
- PBYI 6.30
- ITRG N/A
- 52 Week Low
- PBYI $2.23
- ITRG $0.64
- 52 Week High
- PBYI $7.73
- ITRG $1.28
- Technical
- Relative Strength Index (RSI)
- PBYI 47.45
- ITRG 40.65
- Support Level
- PBYI $2.82
- ITRG $0.88
- Resistance Level
- PBYI $3.12
- ITRG $1.01
- Average True Range (ATR)
- PBYI 0.20
- ITRG 0.05
- MACD
- PBYI -0.03
- ITRG 0.00
- Stochastic Oscillator
- PBYI 14.71
- ITRG 18.60
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.